Search results
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool via Yahoo Finance· 21 hours agoEli Lilly also has exciting pipeline candidates like efsitora alfa, a potential once-weekly insulin ...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 5 days agoHowever, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 22 hours agoA panel of experts convened by the U.S. Food and Drug Administration recently unanimously endorsed...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 2 days agoIt takes a long time.” A potential avenue for relief is to make a GLP-1 drug in pill form. Lilly has...
Re: The Medicare Doughnut Hole
AARP· 6 days agoNovo Nordisk in September launched the MyInsulinRx program, which provides a 30-day supply of insulin for $35 to eligible patients, including the uninsured. The company also ...
Abbott Labs Enters The U.S. Obesity Arena
Investor's Business Daily· 6 days agoBoth are continuous glucose monitors, or CGMs, that aim to keep tabs on blood sugar in real time. Libre Rio is designed for people with type 2 diabetes...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
StreetInsider· 7 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate ...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 4 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Exxon adds some Dem lobbying muscle
Politico· 2 days agoSPOTTED last night at a summer reception for the Options Clearing Corporation at the Capitol, per a tipster: Reps. Brad Sherman (D-Calif.), Dan...
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific...
Morningstar· 4 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
